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Microcystin-LR (MCLR) is a commonly encountered blue-green algal hepatotoxin and a known inhibitor
of cellular protein phosphatase (PP), however, little is known about its neurotoxicity. This study investi-
gated the protein profiles of zebrafish (Danio rerio) brains chronically exposed to MCLR concentrations (2
or 20 lg L1) using the proteomic approach. The results showed that MCLR strikingly enhanced toxin
accumulation and the PP activity in zebrafish brains after 30 d exposure. Comparison of two-dimensional
electrophoresis protein profiles of MCLR exposed and non-exposed zebrafish brains revealed that the
abundance of 30 protein spots was remarkably altered in response to MCLR exposure. These proteins
are involved in cytoskeleton assembly, macromolecule metabolism, oxidative stress, signal transduction,
and other functions (e.g. transporting, protein degradation, apoptosis and translation), indicating that
MCLR toxicity in the fish brain is complex and diverse. The chronic neurotoxicity of MCLR might initiate
the PP pathway via an upregulation of PP2C in the zebrafish brain, in addition to the reactive oxygen spe-
cies pathway. Additionally, the increase of vitellogenin abundance in MCLR exposed zebrafish brains sug-
gested that MCLR might mimic the effects of endocrine disrupting chemicals. This study demonstrated
that MCLR causes neurotoxicity in zebrafish at the proteomic level, which provides a new insight into
MCLR toxicity in aquatic organisms and human beings.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Microcystins (MCs), a group of cyclic heptapeptides, are consid-
ered to be hepatotoxins produced by a number of cyanobacterial
genera. In the past few decades, MCs have become a worldwide
concern due to the significant increase of MCs-producing cyano-
bacterial blooms in eutrophic rivers, lakes, reservoirs and recrea-
tional waters. Among 80 MCs, microcystin-LR (MCLR) is the most
studied and the most toxic (Hoeger et al., 2005). The toxic effects
of MCLR on fish are reported in a large number of studies including
behavioral, histological, and biochemical investigations (Fischer
and Dietrich, 2000; Malbrouck et al., 2003, 2004; Baganz et al.,
2004; Li et al., 2007; Mezhoud et al., 2008a,b; Malécot et al.,
2009; Wang et al., 2010), however most of them focus on its hep-
atotoxicity. Studies show that organic anion transporting polypep-
tides (rodent Oatp/human OATP) appear to be specifically required
for the active uptake of MCs into hepatocytes (Monks et al., 2007;
Feurstein et al., 2009), but Oatp/OATP are also expressed in the
heart, lung, spleen, pancreas, blood–brain-barrier (BBB) and brain
(Hagenbuch and Meier, 2003; Feurstein et al., 2009). Thus, regard-
less of their specific hepatotoxicity, MCs have been found in other
organs with a concomitant display of toxicity. Fischer and Dietrichll rights reserved.
x: +86 0592 2186055.(2000) report MCLR in the brain of Cyprinus carpio fed with toxic
algae. Cazenave et al. (2005) report the presence of microcystin-
RR (MCRR) in the brain of Jenynsia multidentata exposed to
water-dissolved toxin for 24 h. In addition to MCs in the brain of
J. multidentata, Cazenave et al. (2008) also report changes in swim-
ming activity of this fish upon exposure to MCs, suggesting the
probable neurotoxicity of MCs. Taken together, these findings sug-
gest that as a consequence of the high blood perfusion of the brain,
significant amounts of MCs could accumulate in the brain across
the BBB and result in probable neurotoxicity. Actually, the above
hypothesis is supported by the tragic event occurring in Caruaru,
Brazil in February 1996. Among the 131 patients intravenously ex-
posed to various concentrations of MCs, 89% of them presented
immediate signs of neurotoxicity (e.g. dizziness, tinnitus, vertigo,
headache, vomiting, nausea, mild deafness, visual disturbance
and blindness) with a consequent onset of overt hepatotoxicity
and finally succumbed to multi-organ failure (Carmichael et al.,
2001; Soares et al., 2006).
The typical toxicological action of MCs is to inhibit serine/thre-
onine protein phosphatase (PP) (Fischer and Dietrich, 2000;
Gehringer, 2004), followed by hyperphosphorylation of numerous
cellular proteins, thereby resulting in the collapse of the cytoskel-
eton and the loss of cellular integrity (Fischer and Dietrich, 2000;
Batista et al., 2003). Moreover, other toxicity mechanisms such as
oxidative damage and disruption of osmoregulation are also
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Jüttner, 2005; Chen et al., 2006). Ding et al. (2001) demonstrate
that the production of reactive oxygen species (ROS) plays a crucial
role in MCs-induced disruption of cytoskeleton organization and
consequent hepatotoxicity. Thus, the precise mechanism of MCLR
toxicity in organisms has not been well elucidated.
A large number of studies focus on the acute toxicity of MCs
(Malbrouck et al., 2003, 2004; Li et al., 2007; Mezhoud et al.,
2008a,b; Malécot et al., 2009), but few efforts have been devoted
to exploring the chronic effects of MCs on organisms. Chronic
exposure to MCs through drinking water is the main reason for
toxin accumulation in organisms including human beings, consid-
ering that the concentration of MCs is usually a few micrograms
per liter in the water of many eutrophic lakes in the world (Song
et al., 2007; Gurbuz et al., 2009). Our previous study shows that
the chronic toxicity of MCLR is different from its acute toxicity
and the ROS pathway is the main toxic pathway instead of the
PP one (Wang et al., 2010). So, in this study, zebrafish (D. rerio)
were chronically exposed to MCLR (2 or 20 lg L1) for 30 d, the
protein profiles of exposed and non-exposed zebrafish brains were
analyzed using the proteomic approach, and the differentially ex-
pressed proteins were identified using MALDI-TOF/TOF MS. Toxin
content and PP activity in zebrafish brains were also investigated
after the 30 d exposure. Thus, we aimed to explore the chronic
neurotoxicity of MCLR to zebrafish brains, and to identify potential
protein biomarkers so as to understand the damage mechanisms
involved.2. Materials and methods
2.1. Zebrafish exposure experiment
Zebrafish were acclimatized in aerated fresh water tanks for 20
d prior to the experiment at a water temperature of 25 C and a
12 h light/dark cycle, and fed twice a day, 9:00 am and 3:00 pm,
with commercial dry bait. During acclimation, the fish were sup-
plemented with artemia (about 40 mg per fish) three times a week
to maintain nutritional status. Then, fish (weighing 0.7 ± 0.07 g)
were randomly assigned to three experimental groups for expo-
sure to two MCLR concentrations, 2 and 20 lg L1, and non-expo-
sure. Each treatment included two groups with 40 fishes for each
group. The experiments were undertaken in glass tanks
(44  30  28 cm3) with 30 L fresh water and lasted for 30 d under
the same conditions as described above during acclimation. Each
day one-third of the aged water was renewed with fresh water
containing 2 or 20 lg L1 MCLR, or none. No mortality was found
in any treatment during the 30 d exposure. At the end of the exper-
iment, zebrafish brains were dissected and pooled. Then they were
immediately frozen in liquid nitrogen and stored at 80 C for pro-
teomic, toxin content and PP activity analysis.2.2. MCLR analysis
MCLR content in zebrafish brains was analyzed according to the
method of Moreno et al. (2005) with minor modification (Deblois
et al., 2008). Briefly, freeze-dried tissue was homogenized in
0.6 mL of 85% methanol (MeOH) using an ultrasonic disrupter
(Model 450, Branson Ultrasonics, Danbury, CT, USA) at 4 C for
5 min. The homogenate was extracted at 4 C for 6 h and then cen-
trifuged (8000g) at 4 C for 10 min, and the supernatant was recov-
ered. The pellet was extracted again using the same procedure and
the supernatant was pooled with that collected earlier and washed
with the same volume of hexane for 4 h. The hexane layer was dis-
carded and the MeOH layer was completely dried using SpeedVac.
The dried brain extract was resolubilized in 100 lL of 50% MeOHfor toxin analysis using HPLC with a DAD detector. The toxin sep-
aration was performed on a micropher C18 reverse phase column
(3 lm) under isocratic conditions with a mobile phase of 10 mM
ammonium acetate and acetonitrile (7.4:2.6) for 20 min. The toxin
content was quantified using an MCLR standard and expressed as
lg cellular MCLR per mg DW (dry weight).2.3. PP activity analysis
Brain lysate was prepared using tissue protein extraction re-
agent (T-PER, Pierce Biotechnology Inc., Rockford, IL, USA). 0.5 mg
brain tissue was sonicated in 1 mL T-PER reagent and the superna-
tant was recovered by centrifugation (16 000 g) at 4 C for 20 min.
PP activity was analyzed according to the method of Fontal et al.
(1999). Briefly, 35 lL of brain homogenate was mixed with 5 lL
of NiCl2 (40 mM), 5 lL of 5 mg mL1 bovine serum albumin (Sig-
ma) and 35 lL of phosphatase assay buffer (50 mM Tris–HCl,
0.1 mM CaCl2, pH 7.4) and incubated at 37 C for 10 min. Then
120 lL of 100 lM 6,8-difluoro-4-methylumbelliferyl phosphate
(Sigma) was added and it was incubated at 37 C for another
30 min. PP activity was analyzed using a fluorescence microplate
reader at 355 nm (excitation) and 460 nm (emission).2.4. Proteomic analysis
2.4.1. Protein extraction
Frozen fish brains were homogenized in 0.6 mL of 20% TCA/
acetone (w/v) lysis buffer with 20 mM dithiothreitol (DTT) using
an ultrasonic disrupter. The supernatant was removed by centri-
fugation at 17 000 g for 30 min at 4 C, and the pellet was
washed twice with 80% acetone (v/v) and twice with ice-cold
acetone with 20 mM DTT. The pellet was recovered by centrifu-
gation at 17 000 g for 30 min at 4 C each time. Residual acetone
was removed in a SpeedVac for about 5 min. The pellet was dis-
solved in 100 lL rehydration buffer containing 8 M urea, 2%
CHAPS, 2.8 mg mL1 DTT, 0.5% immobilized pH gradient (IPG)
buffer and a trace of bromophenol blue. The solution was centri-
fuged at 20 000g for 30 min at 15 C and the supernatant was
collected for two-dimensional electrophoresis (2-DE) analysis.
The protein content was quantified using the 2-D Quant kit (GE
Healthcare).2.4.2. 2-DE analysis
One hundred and twenty micro gram of each protein sample
was mixed with a rehydration buffer and then loaded onto IPG
strips of linear pH gradient 4–7 (GE Healthcare). Rehydration and
subsequent isoelectric focusing were conducted using the Ettan
IPGphor III Isoelectric Focusing System (Amersham Biosciences,
USA). Rehydration was performed overnight in a strip holder with
340 lL of rehydration buffer. After rehydration, isoelectric focusing
was performed in the following manner: 2 h at 100 V, 2 h at 200 V,
1 h at 500 V, 2 h at 1000 V, 2 h at 4000 V and 6 h at 8000 V. After
the first dimension was run, each strip was equilibrated with about
10 mL equilibration buffer containing 50 mM Tris (pH 8.8), 6 M
urea, 30% glycerol, 2% SDS, 1% DTT and a trace amount of bromo-
phenol blue, for 17 min. The strip was then placed in fresh equili-
bration buffer containing 2.5% iodoacetamide (instead of DTT) for
another 17 min. Subsequently an 11.25% SDS–PAGE second dimen-
sion was performed. Electrophoresis was carried out at 10 mA/gel
for 15 min, followed by a 6 h run at 200 V until the bromophenol
blue front reached the edge of the gels. The proteins were visual-
ized by silver staining and three 2-DE gels were performed for each
sample. Unless stated otherwise, the 2-DE gels shown were repre-
sentative of the three gels performed.
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Silver staining was performed following the method of Wang
et al. (2009). Briefly, the gel was fixed for 2 h initially in a fixation
solution containing 40% (v/v) ethanol and 10% (v/v) acetic acid. It
was then sensitized in a solution containing 30% (v/v) ethanol,
0.2% (w/v) sodium thiosulphate, 6.8% (w/v) sodium acetate and
0.125% (v/v) glutaraldehyde, followed by three Milli-Q water
washes (5 min each time). Then the gel was stained for 20 min in
0.25% (w/v) silver nitrate with 0.015% (v/v) formaldehyde and
washed twice with Milli-Q water (0.5 min each time). The gel
was developed in 2.5% (w/v) sodium carbonate containing
0.0074% (v/v) formaldehyde. The reaction was stopped with 1.5%













2.4.4. Image capture and analysis
Images were made using a Gel-documentation system on a GS-
670 Imaging Densitometer from Bio-Rad (USA) and 2-DE electro-
phoretogram matching software. Images were saved in TIFF format
before analysis. Computerized 2-DE gel analysis (spot detection,
spot editing, pattern matching, database construction) was per-
formed using the ImageMaster 2D Elite (GE Life Science, USA)
and Melanie IV. There were three gels for samples from control
or treated zebrafish brains. After spot detection and matching, spot
intensities were normalized with total valid spot volume in order
to minimize the nonexpression related variations in spot intensity
and hence accurately provide semiquantitative information across
different gels. Spots normalization was done by analyzing the rel-
ative volume (volume percentage). A one-way ANOVA (analysis of
variance) test was used to analyze spot intensities among different
groups. Only protein spots showing a significance (P < 0.05) and at
least a 2.0-fold difference in abundance (ratio of mean normalized
spot volume of treated versus control groups) were considered as
up- or down-regulated. These protein spots of interest were se-
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Fig. 1. MCLR contents (A) and PP activity (B) in the brains of the zebrafish Danio
rerio after 30 d of MCLR exposure (control, 2 and 20 lg L1). Data are expressed as
mean values ± SD (n = 3–4). Symbol ‘*’ indicates a significant difference at P < 0.05
between the control and treatments, while ‘#’ represents a significant difference
between the 2 and 20 lg L1 toxin treatments at P < 0.05.2.4.5. Mass spectrometric analysis
Differentially expressed protein spots in MCLR exposed and
non-exposed brains were manually excised from 2-DE gels. The
gel pieces were washed twice with 200 mM ammonium bicarbon-
ate in 50% acetonitrile/water (20 min at 30 C), then dehydrated
using acetonitrile and spun dry. In gel trypsin digestion was per-
formed by adding 10 ng lL1 trypsin (Promega) in 25 mM ammo-
nium bicarbonate overnight at 37 C. For MALDI-TOF/TOF MS
analysis, 1 lL of the digest mixture was mixed on-target with
1 lL of 100 mM a-cyano-4-hydroxy-cinnamic acid in 50% acetoni-
trile and 0.1% trifluoroacetic acid on the target plate before being
dried and analyzed with a MALDI TOF/TOF mass spectrometer
(4800 Proteomics Analyzer, Applied Biosystems). MALDI TOF MS
and TOF-TOF tandem MS were performed and data were acquired
in the positive MS reflector mode with a scan range from 900 to
4000 Da, and five monoisotopic precursors (S/N > 200) were se-
lected for MS/MS analysis. For interpretation of the mass spectra,
a combination of peptide mass fingerprints and peptide fragmenta-
tion patterns were used for protein identification in an NCBI
nonredundant database using the Mascot search engine
(www.matrixscience.com). All mass values were considered mono-
isotopic, and the mass tolerance was set at 75 ppm. One missed
cleavage site was allowed for trypsin digestion; cysteine carbami-
domethylation was assumed as a fixed modification, and methio-
nine was assumed to be partially oxidized. Results with CI%
(confidence interval%) values greater than 95% were considered
to be a positive identification. The identified proteins were then
matched to specific processes or functions by searching Gene
Ontology (http://www.geneontology.org/).2.5. Statistical tests
All measurements were replicated at least three times and the
data were expressed as mean values ± standard deviation.
Statistical analysis was carried out using one-way ANOVA or an
independent-samples t-test to evaluate whether the means were
significantly different among the groups. Significant differences
were indicated at P < 0.05. Prior to one-way ANOVA, data were
log transformed to meet ANOVA assumptions of normality and
variance homoscedasticity.
3. Results
3.1. Effect of MCLR on toxin accumulation and PP activity in the
zebrafish brain
The toxin content and PP activity in zebrafish brains at the end
of this exposure experiment are shown in Fig. 1. No MCLR was de-
tected in the control while MCLR significantly enhanced toxin
accumulation in MCLR exposed zebrafish brains (Fig. 1A). The toxin
contents were 0.030 and 0.053 lg mg1 DW in the brains exposed
to 2 and 20 lg L1 MCLR (Fig. 1A). Namely, the treated MCLR con-
tent displayed a positively linear relationship with the ambient
toxin concentration (Fig. 1A, P < 0.05). Similarly, the brain PP activ-
ity was also enhanced by MCLR and the PP activity increased 1.3
times in zebrafish brains exposed to 20 lg L1 MCLR (Fig. 1B).
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The representative 2-DE gels of MCLR exposed and non-exposed
zebrafish brains are shown in Fig. 2, and quantitative spot compar-
isons were conducted using image analysis software. On average,
more than 900 proteins spots were detected in each gel using silver
staining and the ImageMaster 2D Elite software. Compared with
the 2-DE gels of the control brains, a total of 30 protein spots from
the treated group was found to significantly alter in abundance
(P2-fold; P < 0.05). Among these altered proteins, seven protein
spots were newly induced in the exposed treatment (one spot




B 100 kD 
10 kD 
MW 





Fig. 2. Representative 2-DE gels of brain proteins in the zebrafish Danio rerio after
the 30 d MCLR exposure. A: control, B: 2 lg L1, and C: 20 lg L1. Whole soluble
proteins from zebrafish brains were separated with 2-DE and visualized using silver
staining. The protein spots altered by MCLR exposure are labeled with numbers. The
molecular weights (MW) and pI scales are indicated. Each gel is representative of
three independent replicates.the 20 lg L1 treatment). In addition, six protein spots were signif-
icantly downregulated and four protein spots were noticeably
upregulated in the 2 lg L1 treatment (Table 1; Fig. 2). In the
20 lg L1 group, twelve protein spots were remarkably downregu-
lated and seven protein spots were markedly upregulated (Table 1;
Fig. 2). These altered proteins were excised and submitted for iden-
tification using MALDI-TOF/TOF MS analysis. All of the protein
spots were successfully identified with CI values greater than
95% (Table 1) and the matched proteins came from the NCBI data-
base for the zebrafish D. rerio. The identified proteins were distin-
guished into 26 different proteins. Of them, four proteins (spots 2,
3, 4 and 17) were involved in cytoskeleton organization, and six
proteins (spots 10, 11, 12, 20, 21 and 28) were related to metabo-
lism. Two proteins (spots 14 and 15) were related to the oxidative
stress response, and five proteins (spots 5, 6, 9, 22 and 23) played a
role in signal transduction. The abundance of PP type 2C alpha 2
(PP2Ca2) was noticeably increased in the 20 lg L1 treatment.
The other proteins were found to be correlated with transport, pro-
tein degradation, apoptosis and translation. It should be noted that
five protein spots (spots 19, 25, 27, 29, and 30) were definitely
identified as the same protein (i.e. vitellogenin 1), although these
spots were differentially distributed in the 2-DE gel (Fig. 2C).4. Discussion
There have been many studies on the toxic effects of MCLR on
aquatic organisms and human beings, but little effort has been de-
voted to exploring the neurotoxicity of MCLR. This study is the first
effort to investigate the biochemical mechanism involved in the
chronic neurotoxicity of MCs on fish brain at the proteomic level,
although MCs probably appear to have presented neurotoxicity
in several previous studies (Cazenave et al., 2005, 2008; Fischer
et al., 2005; Soares et al., 2006; Feurstein et al., 2009). After 30 d
exposure, a significant amount of MCLR was detected in the treated
group (Fig. 1A). This is in line with a study that a carp (C. carpio)
treated with a single dose of 400 lg kg1 DW MCLR demonstrates
the presence of MCLR in the brain 48 h post toxin application
(Fischer and Dietrich, 2000), which allows this toxin to exert its
probable neurotoxicity. However, care needs to be taken with
MCs content in organisms, since the present organic extraction
method can not efficiently extract covalently bound MCs (Williams
et al., 1997; Martins and Vasconcelos, 2009). In this study, MCLR
was extracted from the zebrafish brain exposed to dissolved MCLR
using the same procedure reported by Moreno et al. (2005), which
might omit covalently bound MCLR. However, Lance et al. (2010)
recently demonstrate the accumulation of covalently bound MCs
in Lymnaea stagnalis exposed to toxic cyanobacteria, whereas
bound MCs are not detected in dissolved MCLR exposed L. stagnalis.
Overall, the covalently bound MCLR as well as non-covalently
bound MCLR should be considered with regard to the toxicological
study in future.
Using the proteomic approach, 30 differentially expressed pro-
teins caused by MCLR were identified and these proteins were as-
signed into several groups such as cytoskeleton, metabolism,
oxidative stress, signal transduction, protein degradation, trans-
port, apoptosis and translation related. It is worth emphasizing that
the proteomic response in the zebrafish brain was dependent on
MCLR concentration. Of 30 differentially expressed protein spots,
11 protein spots were observed in the 2 lg L1 treatment while
27 spots were found in the 20 lg L1 group, which might be caused
by a significantly differential toxin accumulation in the zebrafish
brain after the exposure to different MCLR concentrations.
This study showed that MCLR treatment produced oxidative
stress in the zebrafish brain. Particularly, mitochondrial aldehyde
dehydrogenase 2, a target of MCLR attack in a study (Chen et al.,
Table 1
Identification of the differentially expressed proteins in the zebrafish (Danio rerio) brain following MCLR exposure.
Spot id. Accession number Protein score Protein score CI% Peptide count MW/pI Protein description Fold change
2 lg L1 20 lg L1
Cytoskeleton
2 gi|18858539 280 100 22 54.02/5.50 Desmin 2.08 2.65
3 gi|62298523 446 100 13 41.74/5.30 Beta-actin-1 2.22 2.38
4 gi|41054750 61 99.111 13 55.98/6.29 Zgc:66419 2.53 –
17 gi|47086499 116 100 5 27.48/5.08 Tubulin folding cofactor B – 3.40
Metabolism
10 gi|48734808 275 100 14 40.31/6.73 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10 – 2.12
11 gi|41054629 56 97.057 4 30.83/5.99 Methylthioadenosine phosphorylase – 2.06
12 gi|33468556 136 100 4 35.11/6.25 Novel protein similar to human glyoxylate reductase/hydroxypyruvate reductase – 2.12
20 gi|47086189 62 99.243 14 60.75/7.54 Propionyl-CoA carboxylase, beta polypeptide 5.97 2.15
21 gi|55925442 164 100 10 57.17/8.46 3-oxoacid CoA transferase 1a 3.97 2.12
28 gi|41055658 54 95.745 7 34.59/8.35 3-hydroxyisobutyrate dehydrogenase b – Na
Oxidative stress response
14 gi|41393103 302 100 13 55.23/6.18 Aldehyde dehydrogenase 9A1a – 2.09
15 gi|41053732 120 100 7 56.53/5.93 Aldehyde dehydrogenase 2 family (Mitochondrial) a – 2.19
Signal transduction
5 gi|41055564 90 99.999 9 59.12/5.67 Copine I – 2.97
6 gi|71164796 326 100 15 53.53/6.39 Synaptic vesicle membrane protein VAT-1 homolog 3.10 –
9 gi|61806564 63 99.399 6 37.33/5.61 Guanine nucleotide binding protein (G protein), beta polypeptide 2 – 2.10
22 gi|54312133 105 100 6 20.85/6.31 phosphatidylethanolamine binding protein 2.56 2.43
23 gi|47271364 145 100 8 42.06/5.18 protein phosphatase type 2C alpha 2 – 2.23
Transport
7 gi|47264590 414 100 25 73.48/6.81 TPA:TPA_exp: transferrin 4.39 –
8 gi|47777306 89 99.998 8 30.61/6.23 Voltage-dependent anion channel 1 – 2.10
24 gi|11118642 106 100 9 139.51/6.92 Vitellogenin 3 – Na
25 gi|166795887 288 100 16 149.45/8.68 Vitellogenin 1 – Na
27 gi|166795887 546 100 18 149.45/8.68 Vitellogenin 1 – Na
29 gi|166795887 107 100 11 149.45/8.68 Vitellogenin 1 – Na
30 gi|166795887 75 99.962 11 149.45/8.68 Vitellogenin 1 – Na
19 gi|166795887 72 99.929 11 149.45/8.68 Vitellogenin 1 – 3.18
Protein degradation
13 gi|45709356 55 96.12 12 55.98/8.16 Sb:cb283 protein – 2.58
16 gi|47085817 165 100 11 37.57/5.11 Ubiquitin carboxyl-terminal hydrolase L5 3.28 2.55
18 gi|41393111 160 100 5 24.23/5.10 Ubiquitin carboxyl-terminal esterase L1 Na Na
Apoptosis
1 gi|47938859 220 100 14 27.94/4.78 Ywhai protein 3.03 3.86
Translation
26 gi|47085971 114 100 3 16.87/5.18 Eukaryotic translation initiation factor 5A – 2.43
MW: molecular weight. pI: isoelectric point.
Note: variations were calculated as treated/control spot volume ratio and if the result was below 1, it is reported as – control/treated ratio.
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treatment. Similarly, the expression of aldehyde dehydrogenase
9A1a was significantly depressed by MCLR. Aldehyde dehydrogen-
ases are known to participate in aldehyde metabolism via
oxidizing aldehyde to carboxylic acid (Marchitti et al., 2007). Alde-
hydes are highly reactive and cytotoxic, and are involved in various
physiological processes such as enzyme inactivation, protein mod-
ification, and DNA damage (Lindahl, 1992; O’Brien et al., 2005).
Moreover, increasing evidence suggests that some aldehyde meta-
bolites (e.g. 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxy-
phenylglycoladehyde) are neurotoxic, and their intraneuronal
accumulation has been regarded as one mechanism that might
be involved in cell death associated with neurodegenerative
conditions, including Parkinson’s disease and Alzheimer’s disease
(Mattammal et al., 1995; Burke et al., 2003). Thus, MCLR treatment
caused an accumulation of aldehyde via a strong inhibition of alde-
hyde dehydrogenases and subsequently resulted in oxidative
stress (i.e. lipid peroxidation, GSH depletion and reduced antioxi-
dant activity), indicating that MCLR caused neurotoxicity in
zebrafish.
MCLR also caused cytoskeletal disruption in the brain, which is
consistent with several previous studies (Mezhoud et al., 2008a,b;
Malécot et al., 2009; Wang et al., 2010). Desmin is the major mus-
cle-specific intermediate filament protein, and its mutations cause
severe forms of myofibrillar myopathy characterized by partial
aggregation of extrasarcomeric desmin cytoskeleton and structural
disorganization of myofibrils (Kreplak and Bär, 2009). b-actin is a
major cytoskeletal protein composed of actin filaments, which
are abundant in synaptic areas such as pre-synaptic nerve endings
and post-synaptic dendrites (Ratner and Mahler, 1983; Toh et al.,
1976), where they exist as a submembranous cytoskeleton and
are involved in neurite growth, cell adhesion, synapse formation,
and exocytosis of neurotransmitters (Sobue and Kanda, 1989; Asa-
numa et al., 1993). A study shows that b-actin mRNAs are strik-
ingly decreased in the gerbil brain after transient ischemia,
which might be attributable to neuronal death (Asanuma et al.,
1993). A decreased b-actin expression might be caused by oxida-
tive stress due to MCLR attack, since actin could be a direct target
for oxidative modification (Fiaschi et al., 2006; Lassing et al., 2007).
Tubulin folding cofactor B is a ubiquitously expressed tubulin
chaperone protein and binds to a-tubulin (Wang et al., 2005),
and its substantial accumulation leads to microtubule depolymer-
ization, growth cone retraction, and axonal damage followed by
neuronal degeneration (Lopez-Fanarraga et al., 2007). Therefore,
the variations of cytoskeletal proteins indicated that MCLR caused
cellular damage in the brain due to cytoskeletal disruptions.
Our study demonstrated that MCLR treatment exerted a signif-
icant effect on signal transduction. The first affected protein was
copine I, which belongs to the copine family, a family of Ca2+-
dependent and phospholipid-binding proteins. The copines
comprise a pathway for calcium signaling to proteins involved in
a wide range of biological activities including growth control, exo-
cytosis, mitosis, apoptosis, gene transcription, and cytoskeleton
assembly. Especially, it has been reported that copine I plays a role
in regulating the TNF-a signaling pathway (Tomsig et al., 2004).
VAT-1, which was first described in the electric organs of the Paci-
fic electric ray Torpedo californica, is a vital component of synaptic
vesicle formation (Linial et al., 1989) and therefore involved in
nerve function and communication. The heterotrimeric guanine
nucleotide binding protein (G protein) is composed of three
subunits, Ga, Gb and Gc, and each of them has many isoforms
(Cabrera-Vera et al., 2003). Gb2 (guanine nucleotide binding pro-
tein, beta polypeptide 2) is widely expressed throughout the brain
(Betty et al., 1998). A study demonstrates that Gb2 directly inter-
acts with neuropathy target esterase (NTE), and the silence of
Gb2 inhibits the activity of NTE (Chen et al., 2007). The specificdeletion of NTE could cause neurodegeneration in animals (Akas-
soglou et al., 2004; Muhlig-Versen et al., 2005). The phosphatidyl-
ethanolamine binding protein (PEBP) is known to be a Raf kinase
inhibitor protein and it mainly functions as a direct negative regu-
lator of signaling kinase such as mitogen-activated protein kinase
(MAPK), G protein-coupled receptor kinase, nuclear factor kappa
B signaling cascades, and also serine proteases (Yeung et al.,
1999). Overall, the toxin-induced deregulation in signal transduc-
tion was supposed to be an indirect evidence of neurotoxicity in
the zebrafish brain due to MCLR attack.
The most interesting finding of this study is that MCLR en-
hanced the expression of PP2Ca2. The PP activity also increased
with an increasing MCLR concentration in our study, which was
inconsistent with previous studies (Guzman et al., 2003; Mal-
brouck et al., 2003, 2004). Guzman et al. (2003) show that a lethal
dose of MCLR profoundly inhibits PP activity in the nuclear com-
partment. Nevertheless, our previous work on the zebrafish liver
demonstrates an increased hepatic PP activity under MCLR treat-
ment (Wang et al., 2010). Additionally, a previous study shows that
MCRR can up-regulate the expression of the PP2A A subunit in hu-
man amniotic epithelial cells (Fu et al., 2009). In this study, an
upregulation of PP2Ca2 might be responsible for an increased PP
activity in the treated brain. The highly conserved PP2C family is
one of four major groups of serine/threonine PPs in eukaryotes (Co-
hen, 1989), and it is involved in various cellular events and signal-
ing pathways. For example, an overexpression of PP2Ca leads to
G2/M cell cycle arrest and apoptosis through activation of the
p53 protein kinase pathway (Ofek et al., 2003). Also, PP2C is in-
volved in the regulation of AMP-activated protein kinase (AMPK)
(Moore et al., 1991) and the stress-activated protein kinase path-
way (Hanada et al., 1998, 2001). Thus, an overexpression of
PP2Ca2 might affect the protein kinase signaling pathway (e.g.
MAPK and AMPK), which should deepen our understanding about
the toxicological mechanism of MCLR. Alternatively, the increased
expression of PP2Ca2 might merely be a compensatory effect of
the cells in fighting against toxin attack, which really deserves fur-
ther investigation.
Our study showed that several proteins involved in transporting
were affected by MCLR. Transferrin is one of the major serum pro-
teins in eukaryotes and plays a crucial role in iron metabolism by
binding and transporting iron, thus making it unavailable for catal-
ysis of superoxide radical formation via Fenton reactions (Neves
et al., 2009). A depressed transferrin abundance in this study might
be correlated with the toxin-induced oxidative stress, for its de-
crease making iron available for catalysis of the superoxide radical
formation. The voltage-dependent anion channel (VDAC) is instru-
mental in the release of calcium, cytochrome c and apoptosis
inducing factor from the mitochondria inner membrane space,
thus enabling the mitochondria to control cell death (Crompton,
1999; Tsujimoto and Shimizu, 2002). The VDAC protein is also a
determinant of necrosis (Crompton, 1999). Thus, a decreased VDAC
expression could be considered to be aimed at reducing cell death.
Interestingly, MCLR induced the expression of vitellogenin 3 and
significantly increased the abundance of vitellogenin 1 in zebrafish
brains. It should be noted that spots 19, 25, 27, 29, and 30 were
identified as the same protein (vitellogenin 1), and these proteins
are likely to be protein isoforms. Protein isoforms can arise from
alternative mRNA splicing and various post-translational modifica-
tions, such as cleavage, phosphorylation, acetylation, and glycosyl-
ation. Although vitellogenin (Vg) is mostly distributed in fish liver,
it could be expressed in other tissues (e.g. heart and brain) (Ma
et al., 2009). Considering that Vg induction is used as a biomarker
of exposure of fish to estrogen-active substances (Andersen et al.,
2006), we speculated that MCLR might mimic the effects of endo-
crine disrupting chemicals (EDCs), due to this toxin treatment sig-
nificantly increasing Vg expression. In fact, the estrogenic activity
722 M. Wang et al. / Chemosphere 81 (2010) 716–724of this toxin has recently been exemplified by a study which clearly
indicates that MCLR presents estrogenic potential likely by indirect
interaction with estrogen receptors (Oziol and Bouaïcha, 2010).
Meanwhile, MCLR treatment affected protein degradation in
zebrafish brains. Sb:cb283 protein with aminopeptidase activity
is involved in proteolysis. Then, MCLR affected proteolysis in
organism, which is consistent with our previous study (Wang
et al., 2010). Ubiquitin carboxyl-terminal hydrolase L5 and ubiqui-
tin carboxyl-terminal esterase L1 are involved in the ubiquitin
proteasome system, a cellular pathway responsible for the degra-
dation of misfolded and damaged proteins (Ciechanover and Brun-
din, 2003). These proteins may collaborate to affect the turnover of
cellular proteins (e.g. misfolded and damaged proteins) when cells
were stressed by MCLR. Therefore, our study presented a new clue
to understanding the molecular mechanisms underlying MCLR-in-
duced cellular responses.
Brain metabolism is known to be disturbed by MCLR treatment.
NADH [ubiquinone] dehydrogenase 1 alpha subcomplex subunit
10 (NDUFA10) is a subunit of NADH ubiquinone oxidoreductase
(complex I of the respiratory chain, Talpade et al., 2000), and is in-
volved in energy metabolism. Recent studies suggest that complex
I is a potent source of ROS (Murphy, 2009), and the decrease of
NDUFA10 abundance might decrease energy production from the
respiratory chain, however, concomitantly releasing the brain from
oxidative attack via decreasing ROS production. Propionyl-CoA car-
boxylase is involved in the catabolism of essential amino acids,
odd-chain fatty acids, and side chains of cholesterol (Muro et al.,
2001). 3-oxoacid CoA transferase transfers the CoA residue from
succinyl-CoA to acetoacetate to form acetoacetyl-CoA as a mito-
chondrial energy source (Tildon and Sevdalian, 1972). 3-hydroxyi-
sobutyrate dehydrogenase participates in valine, leucine and
isoleucine degradation for the generation of energy (Robinson
and Coon, 1957). Then, an overexpression of propionyl-CoA car-
boxylase, beta polypeptide and 3-oxoacid CoA transferase 1a, and
a newly induced 3-hydroxyisobutyrate dehydrogenase b increased
energy requirement in the treated brain, and was supposed to be a
























Fig. 3. The proposed scheme illustrating cellular events in zebrafish brains upon mi
calmodulin-dependent kinase; ER: endoplasmic reticulum; MAPK: mitogen-activated
mitochondria; NTE: neuropathy target esterase; PEBP: phosphatidylethanolamine bindin
TNF-a signaling pathway; Vg: vitellogenin.duced due to the oxidative stress under MCLR treatment. Methyl-
thioadenosine phosphorylase (MTAP) is a key enzyme in purine
biosynthesis and the methionine salvage pathway. MTAP is usually
abundant in normal tissues, but is known to be deficient in a vari-
ety of cancers (Barker et al., 1997; Chen et al., 1996). Human gly-
oxylate reductase/hydroxypyruvate reductase plays a critical role
in the removal of the metabolic by-product glyoxylate from the li-
ver. Deficiency of this enzyme is the underlying cause of primary
hyperoxaluria type 2 and leads to increased urinary oxalate levels,
formation of kidney stones and renal failure (Booth et al., 2006).
Overall, MCLR might cause a dysfunction in the zebrafish brain
via disturbing energy generation and organic acid metabolism.
MCLR could cause apoptosis in the brain, since toxin treatment
significantly reduced the abundance of Ywhai protein (belonging
to the 14-3-3 family). This 14-3-3 protein is a phosphoserine specific
adapter protein, which can bind the phosphorylated Bad protein and
so prevent apoptosis (Akassoglou et al., 2004; Muslin et al., 1996).
Here, the downregulation of Ywhai protein might lead to cytoplas-
mic release of phosphorylated Bad protein and induce pro-apoptotic
activity. A study shows that global disruption of 14-3-3 function re-
sults in premature cell cycle entry, release of G1 cells from inter-
phase arrest and loss of the S-phase check point after DNA damage,
accompanied by high levels of cell death (Nguyen et al., 2004).
Eukaryotic translation initiation factor 5A (eIF5A) is identified as
the unique hypusine-containing protein (Park et al., 1981), and it
participates in the translational process (Jao and Chen, 2006). Recent
studies indicate that eIF5A may also play a role in cell death (Li et al.,
2004; Taylor et al., 2004). For instance, an overexpression of eIF5A
has been found to induce apoptosis in lung cancer cells (Li et al.,
2004). Thus, the increase of eIF5A abundance indicated that MCLR
resulted in a toxin-inducing apoptosis in the treated brain.5. Conclusions
Our study provided a new insight into MCLR neurotoxicity in
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crocystin-LR (MCLR) exposure. AldH: aldehyde dehydrogenase; CaMKII: calcium/
kinase; MAPKK: mitogen-activated kinase kinase; MCLR: microcystin-LR; Mi:
g protein; PP2C: protein phosphatase 2C; ROS: reactive oxygen species; TNF-a SP:
M. Wang et al. / Chemosphere 81 (2010) 716–724 723revealed that MCLR neurotoxicity induced oxidative stress, and a
dysfunction of cytoskeleton assembly and macromolecule metabo-
lism, with a concomitant interference with signal transduction and
other functions (e.g. protein degradation, transport, apoptosis and
translation), suggesting that MCLR toxicity to the zebrafish brain
was complex and diverse (Fig. 3). Also, the PP activity in the brain
was enhanced with an increasing MCLR concentration, and this
was partly exemplified by an overexpression of PP2Ca2 under tox-
in treatment. Thus, our study firstly demonstrated that the chronic
neurotoxicity of MCLR might initiate the PP pathway via an upreg-
ulation of PP2C in the zebrafish brain, in addition to the ROS path-
way. In addition an increased Vg expression in the treated group
suggested that MCLR might mimic the effects of EDCs, and this
really deserves further study. It should be noted that the responses
in brain were different from liver in our earlier study (Wang et al.,
2010), i.e. MCLR specifically affected transport, protein degrada-
tion, apoptosis and translation in zebrafish brains. Moreover, even
though the affected cellular processes were overlapped in general
functional categories (e.g. metabolism, cytoskeletonal assembly,
oxidative stress and signal transduction), none of the proteins in
the functional category in brain was the same as that from liver.Acknowledgements
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